Aspen has delivered double-digit earnings growth, despite a challenging trading environment characterised by inflationary cost pressures.
The pharmaceutical firm has reported a 31% increase in annual headline earnings per share and has hiked its dividend by 24% to R3.26. Business Day TV unpacked the results with Stephen Saad.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب: